Edition:
United States

Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

29.00USD
26 Sep 2016
Change (% chg)

$0.16 (+0.55%)
Prev Close
$28.84
Open
$28.81
Day's High
$29.12
Day's Low
$28.72
Volume
36,757
Avg. Vol
72,600
52-wk High
$35.79
52-wk Low
$20.08

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.08 December 27 Sep 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 5
(2) OUTPERFORM 2 2 2 2
(3) HOLD 4 5 5 5
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.38 2.38 2.29

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 11 83.40 85.00 82.00 84.94
Quarter Ending Dec-16 11 84.96 86.00 84.00 88.14
Year Ending Dec-16 12 331.13 334.00 329.00 336.60
Year Ending Dec-17 12 368.25 375.14 362.70 376.53
Earnings (per share)
Quarter Ending Sep-16 11 -0.08 -0.02 -0.11 0.00
Quarter Ending Dec-16 11 -0.01 0.04 -0.06 0.05
Year Ending Dec-16 11 -0.47 -0.38 -0.51 -0.05
Year Ending Dec-17 12 0.08 0.61 -0.10 0.36

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 81.27 81.97 0.70 0.86
Quarter Ending Mar-16 78.12 80.89 2.77 3.55
Quarter Ending Sep-15 73.12 73.55 0.43 0.59
Quarter Ending Jun-15 71.65 70.62 1.03 1.44
Quarter Ending Mar-15 69.90 68.15 1.74 2.49

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 83.40 83.40 83.40 83.03 84.94
Quarter Ending Dec-16 84.96 84.96 85.00 84.74 88.14
Year Ending Dec-16 331.13 331.13 331.17 330.29 336.60
Year Ending Dec-17 368.25 368.25 368.50 368.00 376.53

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 1
Year Ending Dec-16 0 0 0 1
Year Ending Dec-17 0 0 0 1
Earnings

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.